Cathepsin B and complement C3 are major comigrants in the estrogen-induced peroxidase fraction of rat uterine fluid

Journal of Submicroscopic Cytology and Pathology

Volumn 33, Issue 3, 2001, Pages 221-230

  Balan, K V ^a   Hollis, V W ^a   Eckberg, W R ^a   Ayorinde, F ^a   Karkera, J D ^b   Wyche, J H ^c   Anderson, W A ^a,d  

^a HOWARD UNIVERSITY   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c BROWN UNIVERSITY   (United States)

^d Department of Biology ^*  (United States)

Author keywords

Cathepsin; Complement; Peroxidase; Uterus

Indexed keywords

CATHEPSIN B; COMPLEMENT COMPONENT C3; DIETHYLSTILBESTROL; ESTROGEN; ISOPROTEIN; PEROXIDASE;

AMINO ACID SEQUENCE; ANIMAL; ARTICLE; BIOSYNTHESIS; BODY FLUID; CHEMISTRY; DRUG EFFECT; FEMALE; GEL CHROMATOGRAPHY; ISOLATION AND PURIFICATION; MASS SPECTROMETRY; METABOLISM; MOLECULAR GENETICS; POLYACRYLAMIDE GEL ELECTROPHORESIS; RAT; UTERUS;

AMINO ACID SEQUENCE; ANIMALS; BODY FLUIDS; CATHEPSIN B; CHROMATOGRAPHY, GEL; COMPLEMENT C3; DIETHYLSTILBESTROL; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ESTROGENS, NON-STEROIDAL; FEMALE; MOLECULAR SEQUENCE DATA; PEROXIDASE; PROTEIN ISOFORMS; RATS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; UTERUS;

EID: 0035412033     PISSN: 11229497     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (69)

1. ANDERSON W.A. and BURNETT C.C., 1979. Reproductive tract peroxidases as endproducts of estrogen-specific gene expression. J. Histochem. Cytochem., 27 (10), 1363-1364.
2. ANDERSON W.A. and ROBINSON T.J., 1982. hCH binding on microvilli differentiates the sensitized ovarian luteal cell, while peroxidase is a marker for estrogen-induced gene activation. Biol. Reprod., 20, 362-376.
3. ANDERSON W.A., KANG Y.H. and DESOMBRE E.R., 1975a. Endogenous peroxidase: specific marker enzyme for tissues displaying growth dependency on estrogen. J. Cell Biol., 64 (3), 668-681.
4. ANDERSON W.A., KANG Y.H. and DESOMBRE E.R., 1975b. Estrogen and antagonist-induced changes in endometrial topography of immature and cycling rats. J. Cell Biol., 64 (3), 692-703.
5. ANDERSON W.A., DESOMBRE E.R. and KANG Y.H., 1977. Estrogen-progesterone antagonism with respect to specific marker protein synthesis and growth by the uterine endometrium. Biol. Reprod., 16, 409-419.
6. ANDERSON W.A., KANG Y.H. and MOHLA S., 1979. Mammalian endogenous peroxidases as cellular markers and as biosynthetic endpoints of hormone mediated activity. Viewpoint from cytochemistry. Rec. Prog. Histochem. Cytochem., 11, 1-26.
7. ANDERSON W.A., AHLUWALIA B.S., WESTNEY L.S., BURNETT C.C. and RUCHEL R., 1984. Cervical mucus peroxidase is a reliable indicator for ovulation in humans. Fertil. Steril., 41 (5), 697-702.
8. ANDERSON W.A., GABRIEL B.W., NERURKAR S.G., WYCHE J.H., YATES P.E. and HANKER J.S., 1986. Peroxidases induced in rat uterus by estrogen administration. II. Cytochemical and biochemical heterogeneity. J. Submicrosc. Cytol. Pathol., 18 (4), 683-690.
9. ANDERSSON C. and FORSBERG J., 1988. Induction of estrogen receptor, peroxidase activity and epithelial abnormalities in the mouse uterovaginal epithelium after neonatal treatment with diethylstilbesterol. Terat. Carcinog. Mutag., 8, 347-361.
10. BATES S.E., DAVIDSON N.E., VALERIUS E.M., FRETER C.E., DICKSON R.B., TAM J.P. and KUDLOW J.E., 1988. Expression of TGF alpha and its messenger nucleic acid in human breast cancer: its regulation by estrogen and its possible functional significance. Mol. Endocrinol., 6, 543-555.
11. BHATTACHARYYA N., RAMSAMMY R., EATMAN E., HOLLIS V.W. and ANDERSON W.A., 1994. Protooncogene, growth factor, growth factor receptor, and estrogen and progesterone receptor gene expression in the immature rat uterus after treatment with estrogen and tamoxifen. J. Submicrosc. Cytol. Pathol., 26 (2), 147-162.
12. BRADFORD M.M., 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding. Anal. Biochem., 72, 248-254.
13. BROCKELMANN J. and FAWCETT D.W., 1969. The localization of endogenous peroxidase in the rat uterus and its induction by estradiol. Biol. Reprod., 1(1), 59-71.
14. BURNETT C., ANDERSON W.A. and RUCHEL R., 1978. Characterization of the estrogen-induced peroxidase by microelectrophoresis. J. Histochem. Cytochem., 26, 382-390.
15. BUTLER W.B., KIRKLAND W.L. and JORGENSEN T.L., 1979. Induction of plasminogen activator by estrogen in a human breast cancer cell line (MCF-7). Biochem. Biophys. Res. Commun., 90, 1328-1334.
16. CAVAILLES V., AUGEREAU P., GARCIA M. and ROCHEFORT H., 1988. Estrogens and growth factors induce the mRNA of the 52 K-pro-cathepsin-D secreted by breast cancer cells. Nucleic Acids Res., 5, 1903-1919.
17. CHAMBON M., CAVALIE-BARTHEZ G., VEITH F., VIGNON F., HALLOWES R. and ROCHEFORT H., 1984. Effect of estradiol on nonmalignant human mammary cells in primary culture. Cancer Res., 44 (12 Pt 1), 5733-5743.
18. CHURG A. and ANDERSON W.A., 1974. Induction of endometrial peroxidase synthesis and secretion by estrogen and estrogen antagonist. J. Cell Biol., 62 (2), 449-459.
19. CULLEN K.J., YEE D., SLY W.S., PERDUE J., HAMPTON B., LIPPMAN M.E. and ROSEN N., 1990. Insulin-like growth factor receptor expression and function in human breast cancer. Cancer Res., 1, 48-53.
20. DE P.K., 1992. Tissue distribution of constitutive and induced soluble peroxidase in rat. Purification and characterization from lacrimal gland. Eur. J. Biochem., 206, 59-67.
21. DESOMBRE E.R. and LYTTLE C.R., 1979. Steroid hormone regulations of uterine peroxidase activity. Adv. Exp. Med. Biol., 117, 157-171.
22. DESOMBRE E.R., ANDERSON W.A. and KANG Y.H., 1975. Identification, subcellular localization, and estrogen regulation of peroxidase in 7,12-dimethylbenz(a)anthracene-induced rat mammary tumors. Cancer Res., 35 (1), 172-179.
23. DICKSON R.B., MCMANAWAY M.E. and LIPPMAN M.E., 1986. Estrogen induced factors of breast cancer cells partially replace estrogen to promote tumor growth. Science, 232, 1540-1543.
24. EGUARAS M.G., SACEDA J.L., LUQUE I. and CONCHA M., 1988. Mitral and aortic valve decalcification by ultrasonic energy. Experimental Report. J. Thorac. Cardiovasc. Surg., 6, 1038-1040.
25. GABRIEL B.W., ECKBERG W.R., WYCHE J.H., MEONES H., HANKER J.S. and ANDERSON W.A., 1986. Peroxidases induced in rat uterus by estrogen administration. I. Synthesis, secretion and immunofluorescent demonstration of fluid enzymes. J. Submicrosc. Cytol. Pathol., 18 (4), 673-682.
26. GHAHARY A. and MURPHY L.J., 1989. Uterine insulin-like growth factor-I receptors: Regulation by estrogen and variation throughout the estrous cycle. Endocrinology, 2, 597-604.
27. GORG A., POSTEL W. and GUNTHER S., 1988. The current state of two-dimensional electrophoresis with immobilized pH gradients. Electrophoresis, 9, 531-546.
28. GREENE G.L. and PRESS M.F., 1986. Structure and dynamics of the estrogen receptor. J. Steroid Biochem., 24, 1-7.
29. HERZOG V. and FAHIMI H.D., 1973. A new sensitive colorimetric assay for peroxidase using 3,3′- diaminobenzidine as hydrogen donor. Anal. Biochem., 55 (2), 554-562.
30. HORWITZ K.B. and MCGUIRE W.L., 1978a. Estrogen control of progesterone receptor in human breast cancer. Correlation with nuclear processing of estrogen receptor. J. Biol. Chem., 253, 2223-2228.
31. HORWITZ K.B. and MCGUIRE W.L., 1978b. Antiestrogens: The mechanism of action and effects in breast cancer. In: 'Breast Cancer. Advances in Research and Treatment'. McGuire W.L. ed., Plenum, New York, pp. 155.
32. HUFF K.K. and LIPPMAN M.E., 1984. Hormonal control of plasminogen activator secretion in ZR-75-1 human breast cancer cells in culture. Endocrinology, 114, 1702-1710.
33. JACOBS M.H. and LYTTLE C.R., 1987. Uterine media proteins in the rat during gestation. Biol. Reprod., 36, 157-165.
34. JEFFERSON W.N., PADILLA-BANKS E. and NEWBOLD R.R., 2000. Lactoferrin is an estrogen responsive protein in the uterus of mice and rats [In Process Citation]. Reprod. Toxicol., 14 (2), 103-110.
35. JENSEN E.V. and DESOMBRE E.R., 1972. Mechanism of action of the female sex hormones. Annu. Rev. Biochem., 41, 203-230.
36. JENSEN E.V., GREENE G.L., CLOSS L.E., DESOMBRE E.R. and NADJI M., 1982. Receptors reconsidered: a 20-year perspective. Recent Prog. Horm. Res., 38, 1-40.
37. KANG Y.H., ANDERSON W.A. and DESOMBRE E.R., 1975. Modulation of uterine morphology and growth by estradiol-17beta and an estrogen antagonist. J. Cell Biol., 64 (3), 682-691.
38. KATZENELLENBOGEN B.S. and NORMAN M.J., 1990. Multihormonal regulation of the progesterone receptor in MCF-7 human breast cancer cells: Interrelationships among insulin/insulin-like growth factor-I, serum, and estrogen. Endocrinology, 2, 891-898.
39. KATZENELLENBOGEN B.S., NORMAN M.J., ECKERT R.L., PELTZ S.W. and MANGEL W.F., 1984. Bioactivities, estrogen receptor interactions, and plasminogen activator-inducing activities of tamoxifen and hydroxyramoxifen isomers in MCF-7 human breast cancer cells. Cancer Res., 44, 112-119.
40. KEEPING H.S. and JELLINCK P.H., 1978. Role of estrogen-induced uterine peroxidase in the metabolism of estradiol in vivo. J. Steroid Biochem., 9 (11), 1049-1054.
41. KING W.J., ALLEN T.C. and DESOMBRE E.R., 1981. Localization of uterine peroxidase activity in estrogen-treated rats. Biol. Reprod., 25 (4), 859-870.
42. KOMM B.S., RUSLING D.J. and LYTTLE C.R., 1986. Estrogen regulation of protein synthesis in the immature rat uterus: the analysis of proteins released into the medium during in vitro incubation. Endocrinology, 118(6), 2411-2416.
43. KUIVANEN P.C. and DESOMBRE E.R., 1985. The effects of sequential administration of 17 beta-estradiol on the synthesis and secretion of specific proteins in the immature rat uterus. J. Steroid Biochem., 22 (4), 439-451.
44. KUIVANEN P.C., CAPULONG R.B., HARINS R.W. and DESOMBRE E.R., 1989. The estrogen-responsive 110K and 74K rat uterine secretory proteins are structurally related to complement component C3. Biochem. Biophys. Res. Commun., 158 (3), 898-905.
45. LAEMMLI U.K., 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature, 227 (259), 680-685.
46. LIN T.H., MUKKU V.R., VERNER G., KIRKLAND J.L. and STANCEL G.M., 1988. Autoradiographic localization of EGFRs to all major uterine cell types. Biol. Reprod., 38, 403-411.
47. LYTTLE C.R. and DESOMBRE E.R., 1977. Generality of oestrogen stimulation of peroxidase activity in growth responsive tissues. Nature, 268 (5618), 337-339.
48. MATHIEU M., VIGNON F., CAPONY F. and ROCHEFORT H., 1991. Estradiol down-regulates the mannose-6-phosphate/insulin-like growth factor-II receptor gene and induces cathepsin-D in breast cancer cells: a receptor saturation mechanism to increase the secretion of lysosomal proenzymes. Mol. Endocrinol., 5 (6), 815-822.
49. MOHAMOOD A.S., GYLES P., BALAN K.V., HOLLIS V.W., ECKBERG W.R., ASSEFFA A., HAN Z., WYCHE J.H. and ANDERSON W.A., 1997. Estrogen receptor, growth factor receptor and protooncogene protein activities and possible signal transduction crosstalk in estrogen dependent and independent breast cancer cell lines. J. Submicrosc. Cytol. Pathol., 29 (1), 1-17.
50. MOHLA S. and ANDERSON W.A., 1979. Role of steroid hormones in mammary cancer. In: 'Endocrine Control of Neoplasia'. Sharma R.K. and Criss W.E. eds., Raven Press, New York, pp. 315-332.
51. MORISSET M., CAPONY F. and ROCHEFORT H., 1986. The 52kD estrogen-induced protein secreted by MCF-7 cells is a lysosomal acidic protease. Biochem. Biophys. Res. Commun., 138, 102-109.
52. MOUTSATSOU P. and SEKERIS C.E., 1997. Estrogen and progesterone receptors in the endometrium. Ann. N.Y. Acad. Sci., 816, 99-115.
53. MUKKU V.R. and STANCEL G.M., 1985. Regulation of epidermal growth factor receptor by estrogen. J. Biol. Chem., 260, 9820-9824.
54. MURPHY L.C., MURPHY L.J., DUBIK D., BELL G.I. and SHIU R.P., 1988. Epidermal growth factor gene expression in human breast cancer cells: regulation of expression by progestins. Cancer Res., 48, 4555-4559.
55. O'MALLEY B.W. and MCGUIRE W.L., 1968. Studies on the mechanism of estrogen-mediated tissue differentiation: regulation of nuclear transcription and induction of new RNA species. Proc. Natl. Acad. Sci. USA, 60 (4), 1527-1534.
56. OSBORNE C.K., KITTEN L. and ARTEAGA C.L., 1989. Antagonism of chemotherapy-induced cytotoxicity for human breast cancer cells by antiestrogens. J. Clin. Oncol., 6, 710-717.
57. REINHART M.P. and MALAMUD D., 1982. Protein transfer from isoelectric focusing gels: the native blot. Anal. Biochem., 123 (2), 229-235.
58. ROCHEFORT H., CAPONY F., GARCIA M., VEITH F., VIGNON F. and WESTLEY B., 1984. Estrogen-induced proteins in human breast cancer cells. Recent results. Cancer Res., 91, 289-294.
59. ROZENGURT E., SINNETT-SMITH J. and TAYLOR-PAPADIMITRIOU J., 1985. Production of PDGF-like growth factor by breast cancer cell lines. Int. J. Cancer, 36, 47-52.
60. SHEVCHENKO A., WILM M., VORM O. and MANN M., 1996. Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal. Chem., 68 (5), 850-858.
61. SODERQUIST G., 1998. Effects of sex steroids on proliferation in normal mammary tissue. Ann. Med., 30 (6), 511-524.
62. STEWART W.W., JOHNSON A., STEWARD M.W., WHALEY K. and KERR M.A., 1990. The effect of antibody isotype on the activation of C3 and C4 by immune complexes formed in the presence of serum: Correlation with the prevention of immune precipitation. Mol. Immunol., 5, 423-428.
63. SUNDSTROM S.A., KOMM B.S., PONCE-DE-LEON H., YI Z. and TEUSCHER C., 1989. Estrogen regulation of tissue-specific expression of complement C3. J. Biol. Chem., 264 (28), 16941-16947.
64. TENG C.T., PENTECOST B.T., CHEN Y.H., NEWBOLD R.R., EDDY E.M. and MCLACHLAN J.A., 1989. Lactotransferrin gene expression in the mouse uterus and mammary gland. Endocrinology, 124 (2), 992-999.
65. VORM O., ROEPSTORFF P. and MANN M., 1994. Improved resolution and very high sensitivity in MALDI-TOF of matrix surfaces made by fast evaporation. Anal. Chem., 66, 3281-3287.
66. WANG G., BHATTACHARYYA N., WILKERSON C., RAMSAMMY R.A., EATMAN E. and ANDERSON W.A., 1994. Estrogen induced peroxidase secretion from the endometrial epithelium: a possible function for the luminal enzyme. J. Submicrosc. Cytol. Pathol., 26 (3), 405-414.
67. WEI L.L., SHERIDAN P.L., KRETT N.L., FRANCIS M.D., TOFT D.O., EDWARDS D.P. and HORWITZ K.B., 1987. Immunologic analysis of human breast cancer progesterone receptors: Structure, phosphorylation, and processing. Biochemistry, 19, 6262-6272.
68. WEI L.L., KRETT L.N., FRANCIS M.D., GORDON D.F., WOOD W.M., O'MALLEY B.W. and HORWITZ K.B., 1988. Multiple human progesterone receptor mRNA and their autoregulation by progestin agonists and antagonists in breast cancer cells. Mol. Endocrinol., 1, 62-72.
69. WILM M., SHEVCHENKO A., HOUTHAEVE T., BREIT S. and SCHWEIGERER L, 1996. Femtomole sequencing of proteins from polyacrylamide gels by nano-electrospray mass spectrometry. Nature, 379 (6564), 466-469.